| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure.
|
J Clin Oncol
|
2011
|
2.78
|
|
2
|
Type I and II endometrial cancers: have they different risk factors?
|
J Clin Oncol
|
2013
|
2.01
|
|
3
|
The reliability of telephone interviews compared with in-person interviews using memory aids.
|
Ann Epidemiol
|
2003
|
1.86
|
|
4
|
Relationship between tumor grade and computed architectural complexity in breast cancer specimens.
|
Hum Pathol
|
2008
|
1.74
|
|
5
|
Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53.
|
EMBO Mol Med
|
2012
|
1.44
|
|
6
|
An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging.
|
Neuroimage
|
2009
|
1.32
|
|
7
|
PIK3CA mutational status and overall survival in patients with cervical cancer treated with radical chemoradiotherapy.
|
Gynecol Oncol
|
2012
|
1.27
|
|
8
|
Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme.
|
J Neurooncol
|
2008
|
1.24
|
|
9
|
Population-based study of pseudoprogression after chemoradiotherapy in GBM.
|
Can J Neurol Sci
|
2009
|
1.24
|
|
10
|
Case-control study of the metabolic syndrome and metabolic risk factors for endometrial cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.20
|
|
11
|
Quantifying the architectural complexity of microscopic images of histology specimens.
|
Micron
|
2008
|
1.19
|
|
12
|
Oncolytic viral therapy for prostate cancer: efficacy of reovirus as a biological therapeutic.
|
Cancer Res
|
2010
|
1.16
|
|
13
|
A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumors.
|
Cancer
|
2003
|
1.15
|
|
14
|
Morphologic complexity of epithelial architecture for predicting invasive breast cancer survival.
|
J Transl Med
|
2010
|
1.07
|
|
15
|
Case-control study of lifetime total physical activity and endometrial cancer risk.
|
Cancer Causes Control
|
2010
|
1.05
|
|
16
|
Prognostic significance of p16 in locally advanced squamous cell carcinoma of the head and neck treated with concurrent cisplatin and radiotherapy.
|
Head Neck
|
2011
|
1.05
|
|
17
|
KRAS mutation testing in the treatment of metastatic colorectal cancer with anti-EGFR therapies.
|
Curr Oncol
|
2010
|
1.05
|
|
18
|
High stromal carbonic anhydrase IX expression is associated with nodal metastasis and decreased survival in patients with surgically-treated oral cavity squamous cell carcinoma.
|
Oral Oncol
|
2012
|
1.05
|
|
19
|
Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03.
|
J Clin Oncol
|
2009
|
1.00
|
|
20
|
Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.
|
Hum Genet
|
2013
|
0.99
|
|
21
|
CXCR4 overexpression is associated with poor outcome in females diagnosed with stage IV non-small cell lung cancer.
|
J Thorac Oncol
|
2011
|
0.98
|
|
22
|
Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes.
|
Breast Cancer Res
|
2012
|
0.96
|
|
23
|
Cancer and Leukemia Group B Pathology Committee guidelines for tissue microarray construction representing multicenter prospective clinical trial tissues.
|
J Clin Oncol
|
2011
|
0.94
|
|
24
|
Genome-wide association study of endometrial cancer in E2C2.
|
Hum Genet
|
2013
|
0.93
|
|
25
|
Case-control study of markers of insulin resistance and endometrial cancer risk.
|
Endocr Relat Cancer
|
2012
|
0.92
|
|
26
|
Copy number analysis of c-erb-B2 (HER-2/neu) and topoisomerase IIalpha genes in breast carcinoma by quantitative real-time polymerase chain reaction using hybridization probes and fluorescence in situ hybridization.
|
Arch Pathol Lab Med
|
2005
|
0.91
|
|
27
|
Basal Ki67 expression measured by digital image analysis is optimal for prognostication in oral squamous cell carcinoma.
|
Eur J Cancer
|
2012
|
0.90
|
|
28
|
Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model.
|
J Control Release
|
2010
|
0.90
|
|
29
|
Bax expression measured by AQUAnalysis is an independent prognostic marker in oral squamous cell carcinoma.
|
BMC Cancer
|
2012
|
0.89
|
|
30
|
Low ERCC1 mRNA and protein expression are associated with worse survival in cervical cancer patients treated with radiation alone.
|
Radiother Oncol
|
2010
|
0.85
|
|
31
|
Risk of endometrial cancer in relation to individual nutrients from diet and supplements.
|
Public Health Nutr
|
2011
|
0.85
|
|
32
|
Associations of overall and abdominal adiposity with area and volumetric mammographic measures among postmenopausal women.
|
Int J Cancer
|
2010
|
0.84
|
|
33
|
Atypical immature cervical metaplasia: immunoprofiling and longitudinal outcome.
|
Hum Pathol
|
2006
|
0.83
|
|
34
|
Case-control study of dietary patterns and endometrial cancer risk.
|
Nutr Cancer
|
2011
|
0.83
|
|
35
|
Anthropometric measures and the risk of endometrial cancer, overall and by tumor microsatellite status and histological subtype.
|
Am J Epidemiol
|
2013
|
0.83
|
|
36
|
Simultaneous siRNA targeting of Src and downstream signaling molecules inhibit tumor formation and metastasis of a human model breast cancer cell line.
|
PLoS One
|
2011
|
0.83
|
|
37
|
Comparing ERCC1 protein expression, mRNA levels, and genotype in squamous cell carcinomas of the head and neck treated with concurrent chemoradiation stratified by HPV status.
|
Head Neck
|
2011
|
0.83
|
|
38
|
Endometrial cancer survival among U.S. black and white women by birth cohort.
|
Epidemiology
|
2006
|
0.82
|
|
39
|
Development and validation of a test dose strategy for once-daily i.v. busulfan: importance of fixed infusion rate dosing.
|
Biol Blood Marrow Transplant
|
2011
|
0.82
|
|
40
|
Gain of OGP, an estrogen-regulated oviduct-specific glycoprotein, is associated with the development of endometrial hyperplasia and endometrial cancer.
|
Clin Cancer Res
|
2004
|
0.81
|
|
41
|
Bladder preservation therapy for muscle-invading bladder cancers on Radiation Therapy Oncology Group trials 8802, 8903, 9506, and 9706: vascular endothelial growth factor B overexpression predicts for increased distant metastasis and shorter survival.
|
Oncologist
|
2013
|
0.80
|
|
42
|
Precursor lesions and prognostic factors in primary peritoneal serous carcinoma.
|
Int J Gynecol Pathol
|
2013
|
0.80
|
|
43
|
Endometrial cancer and a family history of cancer.
|
Gynecol Oncol
|
2013
|
0.80
|
|
44
|
Assessment of ERCC1 and XPF protein expression using quantitative immunohistochemistry in nasopharyngeal carcinoma patients undergoing curative intent treatment.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.79
|
|
45
|
Extraction of tamoxifen and its metabolites from formalin-fixed, paraffin-embedded tissues: an innovative quantitation method using liquid chromatography and tandem mass spectrometry.
|
Cancer Chemother Pharmacol
|
2014
|
0.79
|
|
46
|
COX-2 expression and survival in patients with locally advanced cervical cancer treated with chemoradiotherapy and celecoxib: a quantitative immunohistochemical analysis of RTOG C0128.
|
Int J Gynecol Cancer
|
2013
|
0.79
|
|
47
|
The significance of tumoral ERCC1 status in patients with locally advanced cervical cancer treated with chemoradiation therapy: a multicenter clinicopathologic analysis.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.79
|
|
48
|
Case-control study of inflammatory markers and the risk of endometrial cancer.
|
Eur J Cancer Prev
|
2013
|
0.78
|
|
49
|
Evaluation of E-cadherin, β-catenin and vimentin protein expression using quantitative immunohistochemistry in nasopharyngeal carcinoma patients.
|
Clin Invest Med
|
2014
|
0.78
|
|
50
|
The prognostic value of hemoglobin in patients with anal cancer treated with chemoradiotherapy.
|
Dis Colon Rectum
|
2010
|
0.78
|
|
51
|
Hormone contraception before the first birth and endometrial cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.78
|
|
52
|
Hormonal and reproductive risk factors for sporadic microsatellite stable and unstable endometrial tumors.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.77
|
|
53
|
Case-control study of lifetime alcohol consumption and endometrial cancer risk.
|
Cancer Causes Control
|
2013
|
0.77
|
|
54
|
Circulating Tumor Cells: A Window Into Tumor Development and Therapeutic Effectiveness.
|
Cancer Control
|
2015
|
0.77
|
|
55
|
Practical Applications of Digital Pathology.
|
Cancer Control
|
2015
|
0.75
|
|
56
|
WT1 immunoprofiling and comparison of malignant Mullerian mixed tumors of the female genital tract.
|
Int J Gynecol Pathol
|
2010
|
0.75
|
|
57
|
Molecular Technologies in the Clinical Diagnostic Laboratory.
|
Cancer Control
|
2015
|
0.75
|